Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 49 , ISSUE 2 ( April-June, 2015 ) > List of Articles


Hearing Loss with Amphotericin B Therapy in Patients with Rhinocerebral Aspergillosis: Is it a Reality?

Satyawati Mohindra, Sandeep Mohindra, Karan Gupta, Bhumika Gupta, Dharamveer Singh

Citation Information : Mohindra S, Mohindra S, Gupta K, Gupta B, Singh D. Hearing Loss with Amphotericin B Therapy in Patients with Rhinocerebral Aspergillosis: Is it a Reality?. J Postgrad Med Edu Res 2015; 49 (2):66-69.

DOI: 10.5005/jp-journals-10028-1147

Published Online: 01-12-2016

Copyright Statement:  Copyright © 2015; The Author(s).



Study carried out to investigate the relationship of amphotericin B (AmB) therapy with hearing loss developing in patients with rhinocerebral aspergillosis during prolonged AmB therapy.


To study the effect of prolonged AmB therapy on the hearing acuity of patients suffering from invasive fungal sinusitis. Setting and design: Nonrandomized prospective study carried in Department of Otolaryngology and Head and Neck Surgery from January, 2010 to June, 2013.

Materials and methods

High frequency pure tone audiometry (PTA) and cold caloric test (CCT) were done for all patients before starting of therapy with AmB. Both tests were repeated at 500 mg, 1 and 2 gm of AmB administration. Follow-up was done for all patients at 3 and 6 months after completion of therapy.


Twenty-four patients of invasive fungal sinusitis included. On prolonged AmB therapy some patients had deterioration in hearing. But these changes were not statistically significant. The changes were mild and shift was one grade above or below. It was also seen that the hearing complaints were reported in the middle of the therapy although all these patients had baseline hearing loss.


Amphotericin B does cause some change in hearing pattern; although not statistically significant. A further study is required with more number of patients so as to say definitively that AmB causes a change in hearing. Though these patients have numerous factors which can affect hearing in many ways, a systematic study is required to go a long way in clearing the doubts attached to AmB therapy.

Key message

Amphotericin related hearing loss has not been reported in English literature till date. Our study focuses on the effect of AmB on hearing. Amphotericin B does cause some change in hearing pattern, although not statistically significant. All the patients complained of hearing deterioration while some showed improvement on audiogram (though not significant) showing a paradoxical feature.

How to cite this article

Mohindra S, Gupta B, Mohindra S, Gupta K, Singh D. Hearing Loss with Amphotericin B Therapy in Patients with Rhinocerebral Aspergillosis: Is it a Reality? J Postgrad Med Edu Res 2015;49(2):66-69.

PDF Share
  1. Amphotericin B and its new derivatives— mode of action. Current Drug Metabolism 2009;10(5):459-469.
  2. Amphotericin B: side effects and toxicity. Revista Iberoamericana de Micologia 2009;26(4):223-227.
  3. Chronic invasive aspergillosis in apparently immunocompetent hosts. Clin Infec Dis 1997;24(4):723-733.
  4. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study. Clin Ther 2007 Sep;29(9):1980-1986.
  5. Nephrotoxicity of amphotericin B: early and late effects in 81 patients. Ann Intern Med 1964;61:175-187.
  6. Rhinocerebral mucormycosis: the disease spectrum in 27 patients. Mycoses 2007 Jul;50(4):290-296.
  7. Systemic antifungal agents. Cecil textbook of medicine. Reed Elsevier India Pvt Ltd 2008;2(23): 2333-2338.
  8. Potential ototoxicity from triamcinolone, neomycin, gramicidin and nystatin (Tri-Adcortyl) cream. J Laryngol Otol 2005 Jan;119(1);48-50.
  9. Cryptococcal meningitis: presentation as sudden deafness. Am J Otol 1985 Sep;6(5):435-437.
  10. Disseminated histoplasmosis presenting as a unilateral nerve VIII mass: a case report. Otol Neurotol 2006 Oct;27(7):1014-1016.
  11. Facial paralysis secondary to tympanic mucormycosis: case report. Am J Otol 1994 May:15(3):413-414.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.